Howard Robin is President and Chief Executive Officer of Nektar Therapeutics (NKTR). The company reported total compensation of $6,256,954 for fiscal year 2025.
| Salary | $1,106,282 |
|---|---|
| Bonus | $0 |
| Stock awards | $942,081 |
| Option awards | $2,986,535 |
| Non-equity incentive plan | $1,106,282 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $115,774 |
| Total | $6,256,954 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Nektar Therapeutics filed April 24, 2026, accession 0001140361-26-016708.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $1,106,282 | $0 | $942,081 | $2,986,535 | $1,106,282 | $0 | $115,774 | $6,256,954 |
| FY2024 | President and Chief Executive Officer | $1,084,590 | $0 | $0 | $1,596,122 | $976,131 | $0 | $105,850 | $3,762,693 |
| FY2023 | President and Chief Executive Officer | $1,084,590 | $0 | $0 | $927,160 | $1,030,361 | $0 | $93,465 | $3,135,576 |
Totals as disclosed in each year's own compensation disclosure for Nektar Therapeutics.
| Peer-group chief executive median | $5,215,304 |
|---|---|
| Difference from that median | $1,041,650 |
| Percentile within the disclosed peer group | 58th |
| Peers with a disclosed figure | 12 |
Medians and percentiles are computed across the peer group Nektar Therapeutics discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Howard Robin this page | President and Chief Executive Officer | $6,256,954 |
| Jonathan Zalevsky | Chief Research and Development Officer | $2,320,358 |
| Sandra Gardiner | Interim Chief Financial Officer | $686,400 |
| Mark Wilson | Former Chief Legal Officer | $667,901 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Nektar Therapeutics compensation brief.
Howard Robin's compensation sits inside Nektar Therapeutics's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.